27.9 C
New York
Thursday, June 1, 2023

Subscribe

Profile

Pfizer looks past COVID with $43 bln deal for cancer drug maker Seagen

March 13 (Reuters) – Pfizer Inc (PFE.N) on Monday struck a $43 billion deal to acquire Seagen Inc (SGEN.O) and its targeted cancer therapies as it braces for a steep fall in COVID-19 sales and generic competition for some top-selling drugs. Seagen marks Pfizer’s largest purchase in a string of …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

158,783FansLike
398,411FollowersFollow
2,180SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x